Full Press Release Details
dupixent dupilumab approved in china as the first ever biologic medicine for patients with chronic obstructive pulmonary disease copd.
REGN
dupixent dupilumab approved in china as the first ever biologic medicine for patients with chronic obstructive pulmonary disease copd
Key Takeaway: dupixent dupilumab approved in china as the first ever biologic medicine for patients with chronic obstructive pulmonary disease copd